226 related articles for article (PubMed ID: 8137297)
1. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
[TBL] [Abstract][Full Text] [Related]
2. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
Casey G; Lo-Hsueh M; Lopez ME; Vogelstein B; Stanbridge EJ
Oncogene; 1991 Oct; 6(10):1791-7. PubMed ID: 1923504
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes.
Theile M; Hartmann S; Scherthan H; Arnold W; Deppert W; Frege R; Glaab F; Haensch W; Scherneck S
Oncogene; 1995 Feb; 10(3):439-47. PubMed ID: 7845668
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11.
Negrini M; Sabbioni S; Possati L; Rattan S; Corallini A; Barbanti-Brodano G; Croce CM
Cancer Res; 1994 Mar; 54(5):1331-6. PubMed ID: 8118824
[TBL] [Abstract][Full Text] [Related]
8. Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein.
Cajot JF; Anderson MJ; Lehman TA; Shapiro H; Briggs AA; Stanbridge EJ
Cancer Res; 1992 Dec; 52(24):6956-60. PubMed ID: 1458487
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
[TBL] [Abstract][Full Text] [Related]
10. Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25.
Plummer SJ; Adams L; Simmons JA; Casey G
Oncogene; 1997 May; 14(19):2339-45. PubMed ID: 9178910
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumorigenesis by the breast cancer cell line MCF-7 following transfer of a normal human chromosome 11.
Negrini M; Castagnoli A; Sabbioni S; Recanatini E; Giovannini G; Possati L; Stanbridge EJ; Nenci I; Barbanti-Brodano G
Oncogene; 1992 Oct; 7(10):2013-8. PubMed ID: 1408142
[TBL] [Abstract][Full Text] [Related]
12. p53 mutational status and survival of human breast cancer MCF-7 cell variants after exposure to X rays or fission neutrons.
Balcer-Kubiczek EK; Yin J; Lin K; Harrison GH; Abraham JM; Meltzer SJ
Radiat Res; 1995 Jun; 142(3):256-62. PubMed ID: 7761574
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.
Katayose D; Gudas J; Nguyen H; Srivastava S; Cowan KH; Seth P
Clin Cancer Res; 1995 Aug; 1(8):889-97. PubMed ID: 9816059
[TBL] [Abstract][Full Text] [Related]
14. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
[TBL] [Abstract][Full Text] [Related]
15. Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells.
Ogretmen B; Safa AR
Oncogene; 1997 Jan; 14(4):499-506. PubMed ID: 9053847
[TBL] [Abstract][Full Text] [Related]
16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
17. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
18. Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles.
Runnebaum IB; Yee JK; Kieback DG; Sukumar S; Friedmann T
Anticancer Res; 1994; 14(3A):1137-44. PubMed ID: 8074464
[TBL] [Abstract][Full Text] [Related]
19. p53 mutation and tamoxifen resistance in breast cancer.
Elledge RM; Lock-Lim S; Allred DC; Hilsenbeck SG; Cordner L
Clin Cancer Res; 1995 Oct; 1(10):1203-8. PubMed ID: 9815913
[TBL] [Abstract][Full Text] [Related]
20. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
